banner
IAVI Report Archives 

IAVI Report provides comprehensive coverage of the AIDS vaccine field from the latest scientific research to policy, advocacy and community perspectives, bringing news and analysis, adding context and underscoring trends and gaps in the search for an AIDS vaccine. IAVI Report is published six times a year and has a global readership of more than 14,000 recipients in over 130 countries.

2001

Vol. 5 (10), Oct. - Dec. 2001

 

In this issue (download PDF)

  • AIDS and vaccine development in Asia
  • VaxGen's Phase III Trial: Working with a Drug User Cohort
    Thailand Prepares for a New Phase III Trial
  • New in the Pipeline: Australia's Prime-Boost Vaccines
    Thailand, AIDS and Vaccines
  • Viewpoint: HIV Vaccine Development Needs More Focus and Closer Collaborations
  • Helping Pediatric Vaccines Grow Up
  • AIDS Vaccines 2001: Meeting Briefs
  • HVTN Plans for Phase III Prime-Boost Trial
  • Brazil Hosts Meeting for Latin American AIDS Advocates
  • Industry Insider
  • IAVI News
  • Vaccine Briefs

Vol. 5 (8), July - Sep. 2001

 

In this issue (download PDF)

  • Special report: Women and AIDS vaccines
  • AIDS Vaccines and HIV Transmission via Breastfeeding
    Holding HIV at Bay: What Keeps Exposed Babies Uninfected
  • Women and HIV in Kenya
  • Closing In On Immune Protection in the Women of Pumwani
  • HLA Genes and Immunity
  • Exposed Sero-negative Cohorts
  • Possibly, A Vaccine Against Herpes�But For Women Only?
  • High-Risk Women in a New York Phase III Trial
  • Gender, HIV Transmission and Vaccines
  • Women, HIV Risk and Vaccines in a Rural African Community
  • Vaccine Briefs

Vol. 5 (7), Apr. - June 2001

 

In this issue (download PDF)

  • A global health fund: One step closer
  • U N Draft Declaration
  • Haiti: AIDS Vaccine Trial Begins
  • AIDS Vaccine Tax Legislation P roposed in U.S. and U.K.
  • Laying Groundwork for AIDS Vaccines in Developing Countries:
  • A New Research Center Tackles AIDS Vaccines
  • Vaccine Briefs

Vol. 5 (6), Feb. - Mar. 2001

 

In this issue (download PDF)

  • Keystone Symposium: New vaccine candidates - and a major new player
  • Retrovirus 2001: More Animal Studies, More Promise
  • Supervised Treatment Interruption and Control of HIV
  • From The Editor
  • "The Wayward Search for an AIDS Vaccine"
  • IAVI Translations
  • IADS in India
  • Vaccine Briefs

Vol. 5 (5), Dec. 2000 - Jan. 2001

 

In this issue (download PDF)

  • A new generation of T-cell assays comes to vaccine trials
  • Gates Foundation Pledges "Challenge Grant" to IAVI
  • Phase I DNA Vaccine Trial Begins in Nairobi
  • Letter from the Editor
  • Nigeria Workshop Builds Consensus on HIV Vaccine Action Plan
  • Perspectives on AIDS Vaccines
  • Cohorts, Communities and HIV Vaccines: On the Ground in Africa
  • Vaccine Briefs

2000

Vol. 5 (4), Sep. - Nov. 2000

 

In this issue (download PDF)

  • Gallo Meeting features new protection data from primates
  • The Debate on Tat
  • New Vaccine Study - A Significant Advance
  • IAVI Launches Two Vaccine Trials in Oxford
  • Reports from Durban
  • NIAID Announces International Vaccine Trial Sites
  • AIDS Vaccine Work in Europe
  • Palm Beach Meeting Spotlights Novel Vaccine Designs
  • IAVI Restructures its SAC
  • Industry Insider

Vol. 5 (3), July - Aug. 2000

 

In this issue (download PDF)

  • Next front in HIV vaccines: Gearing up for large-scale clinical trials
  • NIAID Launches New HIV Vaccine Trials Network
  • Other NIAID Intiatives
  • Viewpoint: Vaccine Access Issues Need Attention Now
  • Canadian AIDS Meeting Highlights Vaccine Development
  • Canada Announces C$120 Million Plans to Fight AIDS in Developing Countries
  • African Health Ministers Discuss Strategies to Fight AIDS, Boost Vaccine Efforts
  • HIV Vaccine and Prevention Research and NIAID
  • UNAIDS Global Estimates

Vol. 5 (2), Apr. - June 2000

 

In this issue (download PDF)

  • Paris meeting spotlights renewed focus on antibodies
  • Enhancing Antibodies: A Concern for HIV Vaccine Trials?
  • IAVI Task Force on Antibodies
  • IAVI Launches Project to Develop Oral HIV Vaccine
  • Phase II "Prime-Boost" Trial in Brazil, Haiti and Trinidad
  • Report from 3rd Conference on Vaccine Research
  • The View from SmithKline
  • Vaccines, IAVI at Durban
  • Vaccine Briefs

Vol. 5 (1), Jan. - Mar. 2000

 

In this issue (download PDF)

  • Higher profile for AIDS vaccines at retrovirus conference
  • Therapeutic HIV Vaccines
  • U.S President Promotes Vaccines
  • Moving IAVI's Scientific Program Forward
  • IAVI Launches AAV Project
  • EU Funds South african Vaccine Efforts
  • Netherlands Contributes to IAVI
  • An Interview with Sarah Rowland-Jones
  • Viewpoint: Research on Live Attenuated Vaccines
  • Economics of AIDS Vaccines
  • Industry Insider
  • Vaccine Briefs


1999

Vol. 4 (5), Nov. - Dec. 1999

 

In this issue (download PDF)

  • Researchers increasingly optimistic about prospects for AIDS vaccine
  • South African Initiative Makes First Vaccine Awards
  • "AIDS in Africa" Meeting
  • Commonwealth Leaders Urge Support for AIDS Vaccines
  • European Union Funds AIDS Vaccine Program
  • An Interview with Norman Letvin
  • AIDS Vaccines at Gallo Meeting
  • At a Glance: HIV in Africa
  • Industry Insider
  • Vaccine Briefs

Vol. 4 (4), Sep. - Oct. 1999

 

In this issue (download PDF)

  • Conducting HIV vaccine trials around the world: What we've learned so far
  • A long, rocky path: an interview with Uganda's Roy Mugerwa
  • From "guinea pig" fears to Phase II trials
  • Studying the volunteers
  • The ebbs and flows of AIDS vaccine trials
  • ALVAC Prime Boost Trial Results Announced
  • PMC's Canarypox Vectors
  • Viewpoint: Do HIV Clades Really Matter?
  • AIDS Vaccine Glossary
  • Vaccine Briefs

Vol. 4 (2), July - Aug. 1999

 

In this issue (download PDF)

  • UNAIDS to publish guidelines on ethics of vaccine trials
  • Gates Gives IAVI US$25 Million
  • Bangkok Conference Highlights Global Vaccine Issues
  • Vaccines Still A Side Issue at Retrovirus Conference
  • Keystone Holds Meeting on HIV Vaccines
  • World Bank, EC Look to Boost AIDS Vaccine Development
  • AIDS Vaccines and Biotech Companies
  • India Launches AIDS Vaccine Program
  • Vaccine Briefs

 

Vol. 4 (1), Jan. - Mar. 1999

 

In this issue (download PDF)

  • Whole killed AIDS vaccines: Time for a closer look
  • Whole Killed Vaccines for Animal Retroviruses
  • IAVI Fast-Tracks Two Vaccine Approches
  • An Interview with Neal Nathanson
  • OAR Council Reviews Vaccine Effort
  • London Debate on Live Attenuated AIDS Vaccines
  • U.S. Army's AIDS Budget Cut
  • AIDS in Kenya
  • Industry Insider
  • Global AIDS Map
  • Letters to the Editor
  • Vaccine Briefs


1998

Vol. 3 (4), Oct. - Dec. 1998

 

In this issue (download PDF)

  • Geneva overview: Vaccines at the 12th World AIDS Conference
  • Remembering Mary Lou Clements-Mann
  • One Trial, Many Opinions
  • IAVI at Geneva
  • HIV "Resistant" Individuals May Point to a Vaccine
  • UNAIDS Ethics Meeting
  • A Closer Look at Vaccine Trial Participants
  • Vaccines at the Human Virology Meeting
  • NIH's AIDS Vaccine Panel Reviews Changes, Vectors
  • Letters to the Editor
  • Vaccine Briefs

Vol. 3 (3), July - Sep. 1998

 

In this issue (download PDF)

  • HIV DNA vaccines move slowly into human trials
  • IAVI Launches Scientific Blueprint
  • The Outlook for Key HIV DNA Vaccine Programs
  • An Interview with Margaret Liu
  • AIDS in South Africa
  • South Africa's Explosive AIDS Epidemic
  • VaxGen gets Approval for U.S. Efficacy Study
  • Industry Insider
  • Vaccine Briefs

Vol. 3 (2), Apr. - June 1998

 

In this issue (download PDF)

  • Canary pox HIV vaccine trial set to begin in Uganda
  • HIV Vaccine Purchase Fund
  • Vaccines Low on the Agenda at 5th Retrovirus Conference
  • Using Viral Load in HIV Vaccine Trials
  • UNAIDS Organizes Meetings on Ethics of HIV Vaccine Trials
  • An Interview with Patuer Merieux Connaught's Michel Klein
  • Pastuer Merieux Connaught's HIV Vaccine Pipeline
  • Palm Springs Meeting on HIV Vaccines
  • NIAID Meetings on Vectors
  • Viewpoints: Gender Issues and HIV Vaccines
  • IAVI in Geneva

Vol. 3 (1), Jan. - Mar. 1998

 

In this issue (download PDF)

  • Using recombinant vectors as HIV vaccines
  • AIDS in Africa Meeting
  • Vector-based HIV Vaccines (Chart)
  • The Outlook for Leading Vector-based HIV Vaccines
  • An Interview with Andrew McMichael
  • New UNAIDS Estimates on the Global Epidemic
  • IAVI Research Awards
  • Appeal for Support
  • Industry Insider
  • Vaccine Briefs

 

1997

Vol. 2 (3), Oct. - Dec. 1997

 

In this issue (download PDF)

  • Proposed live HIV vaccine trials face safety, production hurdle
  • AIDS in Asia Meeting
  • IAVI on Live Attenuated Vaccines
  • Key Changes at Merck and Chiron
  • Making the Case for the Live Attenuated Approach
  • Developing a Different Kind of Live HIV Vaccine
  • Remebering Princess Diana
  • IAVI Unveils Website
  • Letters to the Editor
  • Vaccine Briefs

Vol. 2 (2), Summer 1997

 

In this issue (download PDF)

  • U.S. president calls for AIDS vaccine by 2007
  • A Report from the Conference on Advances in AIDS Vaccines
  • HIV Subtypes May be Irrelevant
  • Report Suggests Goat Virus Neutralizes HIV
  • An Interview with David Baltimore
  • AIDS in India
  • Facts About AIDS in India
  • Indo-U.S. Meeting on HIV Vaccines
  • International Call for Action & list of Endorsing Nations
  • IAVI Update

 

Vol. 2 (1), Winter 1997

 

In this issue (download PDF)

  • Live-attenuated AIDS vaccines: New safety findings reported
  • Scientific Program Launched
  • Studying HIV Vaccines in Thailand
  • ALVAC Trial Moves forward in Uganda
  • IAVI Issues Report on Intellectual Property Rights
  • Developing HIV-DNA Vaccines
  • Baltimore to Head NIH AIDS Vaccine Panel
  • Leading International Organizations Fund IAVI
  • The Global AIDS Epidemic: No Place on Earth Untouched

 

1996

Vol. 1 (1), Summer 1996

 

In this issue (download PDF)

  • Why an HIV vaccine is scientifically possible
  • A View from Uganda
  • Progress On AIDS Vaccines
  • Industry Perspective
  • IAVI Launched
  • Community Leaders Advise IAVI
  • The Global Spread of HIV